Related Experiment Video

Updated: Aug 10, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis

K G Warren, I Catz

Annals of Neurology

|February 1, 1987

Abstract:

Free and bound levels of myelin basic protein (MBP) and anti-myelin basic protein (anti-MBP) antibodies were measured by radioimmunoassay in the cerebrospinal fluid of patients with multiple sclerosis who were experiencing acute exacerbations or progressing disease. In a cross-sectional study, free levels of MBP correlated with those of free anti-MBP, and bound MBP levels correlated with those of bound anti-MBP in both groups of patients with active disease. However, acute exacerbations of multiple sclerosis were characterized by higher free MBP and anti-MBP levels with lower levels of bound fractions. Conversely, patients with progressing disease had higher titers of bound than free fractions. Longitudinal studies of individual patients confirmed the association of higher titers of free anti-MBP with acute exacerbations and higher levels of bound anti-MBP with chronic progressing disease.

More Related Videos

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Articles linked to this work by shared authors, journal, and citation graph.

Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014

Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2008

Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment.

European journal of neurology·2006

Geographic and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965-1994.

Neuroepidemiology·2003

Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.

Annals of neurology·2001

Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis.

Annals of neurology·2001

See all related articles